Advertisement

Serum Biomarkers and Trafficking Defects in Peripheral Tissues Reflect the Severity of Retinopathy in Three Brothers Affected by Choroideremia

  • Natalia Strunnikova
  • Wadih M. Zein
  • Chris Silvin
  • Ian M. MacDonaldEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 723)

Abstract

Choroideremia (CHM) is an X-linked form of retinal degeneration, caused by loss of function mutations in the CHM gene that encodes Rab Escort Protein 1 gene (REP1). REP1 is a key regulator of vesicular trafficking, phagosome fusion, and maturation. We investigated the effects of different CHM mutations in monocytes derived from CHM patients. Phagocytosis in monocytes was tracked with a pH-dependent dye conjugated with E. coli, and the rate of degradation of engulfed material was determined using labeled DQTM-Ovalbumin (Molecular Probes, Eugene, OR). Monocytes (CD14+ fraction) from 6 age-matched controls and 3 CHM patients (brothers) with the same mutation in CHM were compared for different aspects of intracellular vesicle transport. The three brothers demonstrated a large degree of variability in trafficking defects and serum levels of PEDF, VEGF, and MCP1 factors, which correlated with the clinical severity of their disease. We demonstrated that peripheral cells from CHM patients have characteristic defects that have not previously been recognized and could be used as alternative models to study the cellular effects of different mutations in the CHM gene and the mechanisms surrounding the progressive retinal degeneration in this condition.

Keywords

CSNB CSNB1A CSNB2A CANA1F NYX GRM6 TRMP1 

References

  1. Becq F (2010) Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Drugs 70:241–259PubMedCrossRefGoogle Scholar
  2. Gordiyenko NV, Fariss RN, Zhi C et al (2009) Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 51:1143–1150PubMedCrossRefGoogle Scholar
  3. Jacobson SG, Cideciyan AV, Sumaroka A et al (2006) Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 47:4113–4120PubMedCrossRefGoogle Scholar
  4. MacDonald IM, Sereda C, McTaggart K et al (2004) Choroideremia gene testing. Expert Rev Mol Diagn 4:478–484PubMedCrossRefGoogle Scholar
  5. Moosajee M, Gregory-Evans K, Ellis CD et al (2008) Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Hum Mol Genet 17:3987–4000PubMedCrossRefGoogle Scholar
  6. Rak A, Pylypenko O, Niculae A et al (2004) Structure of the Rab7:REP-1 complex: insights into the mechanism of Rab prenylation and choroideremia disease. Cell 117:749–760PubMedCrossRefGoogle Scholar
  7. Reynolds R, Hartnett ME, Atkinson JP et al (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50:5818–5827PubMedCrossRefGoogle Scholar
  8. Rudolph G, Preising M, Kalpadakis P et al (2003) Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet 24:203–214PubMedCrossRefGoogle Scholar
  9. Sieving PA, Niffenegger JH, Berson EL (1986) Electroretinographic findings in selected pedigrees with choroideremia. Am J Ophthalmol 101:361–367PubMedGoogle Scholar
  10. Strunnikova NV, Barb J, Sergeev YV et al (2009) Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients. PLoS One 4:e8402PubMedCrossRefGoogle Scholar
  11. Tolmachova T, Anders R, Abrink M et al (2006) Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest 116:386–394PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Natalia Strunnikova
    • 1
  • Wadih M. Zein
    • 1
  • Chris Silvin
    • 2
  • Ian M. MacDonald
    • 3
    Email author
  1. 1.Ophthalmic Genetics and Visual Function BranchNational Eye Inst/NIHBethesdaUSA
  2. 2.Genetics and Molecular Biology BranchNational Human Genome Research Institute NIHBethesdaUSA
  3. 3.Department of OphthalmologyUniversity of AlbertaEdmontonCanada

Personalised recommendations